Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical practice. Hereditary angioedema.

× No keyword cloud information.

150 in total

1. Danazol-Induced Hepatocellular Carcinoma in a Patient with Hereditary Angioedema.

Authors: Muhammed Hameed Thoufeeq; Javaid Ishtiaq; Mohamed Abuzakouk
Journal: J Gastrointest Cancer Date: 2012-09

2. C1 esterase inhibitor (human).

Authors:
Journal: P T Date: 2010-07

Review 3. The new era of C1-esterase inhibitor deficiency therapy.

Authors: Louanne Marie Tourangeau; Bruce L Zuraw
Journal: Curr Allergy Asthma Rep Date: 2011-10 Impact factor: 4.806

4. Availability of and access to orphan drugs: an international comparison of pharmaceutical treatments for pulmonary arterial hypertension, Fabry disease, hereditary angioedema and chronic myeloid leukaemia.

Authors: Carl Rudolf Blankart; Tom Stargardt; Jonas Schreyögg
Journal: Pharmacoeconomics Date: 2011-01 Impact factor: 4.981

5. The autoreactivity of B cells in hereditary angioedema due to C1 inhibitor deficiency.

Authors: A Kessel; R Peri; R Perricone; M D Guarino; Z Vadasz; R Novak; T Haj; S Kivity; E Toubi
Journal: Clin Exp Immunol Date: 2012-03 Impact factor: 4.330

6. Improving patient outcomes in hereditary angioedema: reducing attack frequency using routine prevention with C1 inhibitor concentrate.

Authors: Nina Dominas; Thomas K Hoffmann; Murat Bas; Jens Greve
Journal: BMJ Case Rep Date: 2014-05-21

Clinical practice. Hereditary angioedema.

1. Danazol-Induced Hepatocellular Carcinoma in a Patient with Hereditary Angioedema.

2. C1 esterase inhibitor (human).

Review 3. The new era of C1-esterase inhibitor deficiency therapy.

4. Availability of and access to orphan drugs: an international comparison of pharmaceutical treatments for pulmonary arterial hypertension, Fabry disease, hereditary angioedema and chronic myeloid leukaemia.

5. The autoreactivity of B cells in hereditary angioedema due to C1 inhibitor deficiency.

6. Improving patient outcomes in hereditary angioedema: reducing attack frequency using routine prevention with C1 inhibitor concentrate.

7. The complex alteration in the network of IL-17-type cytokines in patients with hereditary angioedema.

8. Monoclonal gammopathy of undetermined significance: significant beyond hematology.

9. C-reactive protein levels in hereditary angioedema.

10. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.